ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 237.20
-0.40 (-0.17%)
Jul 21, 2026, 11:18 AM CET
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 52.64 billion as of July 20, 2026. Its market cap has increased by 22.55% in one year.
Market Cap
52.64B
Enterprise Value
51.51B
Revenue
6.56B
Ranking
n/a
PE Ratio
41.12
Stock Price
237.20
ChartMarket Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 52.64B, an increase of 662.06%. That is a compound annual growth rate of 10.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 52.64B | 4.11% |
| Dec 30, 2025 | 50.56B | 43.68% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.46T |
| Genmab | 114.74B |
| Coloplast | 95.20B |
| Demant | 58.59B |
| H. Lundbeck | 41.26B |
| Zealand Pharma | 20.75B |
| Ambu A/S | 18.23B |
| Bavarian Nordic | 14.06B |